Compare PHAR & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | PGC |
|---|---|---|
| Founded | 1988 | 1921 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 836.7M |
| IPO Year | 2020 | 1997 |
| Metric | PHAR | PGC |
|---|---|---|
| Price | $12.94 | $46.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $38.33 | ★ $40.50 |
| AVG Volume (30 Days) | 4.5K | ★ 212.9K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | ★ 13.51 |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $282,995,000.00 |
| Revenue This Year | $10.04 | $32.39 |
| Revenue Next Year | $2.51 | $12.64 |
| P/E Ratio | $3,041.22 | ★ $59.38 |
| Revenue Growth | N/A | ★ 24.05 |
| 52 Week Low | $10.55 | $24.45 |
| 52 Week High | $21.34 | $49.14 |
| Indicator | PHAR | PGC |
|---|---|---|
| Relative Strength Index (RSI) | 38.08 | 52.95 |
| Support Level | $11.88 | $44.79 |
| Resistance Level | $13.61 | $47.18 |
| Average True Range (ATR) | 0.46 | 1.50 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 3.92 | 75.18 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.